Scalzulli PR - Search Results

1

Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.

Melillo L, Tieghi A, Candoni A, Radaelli F, Ciancia R, Specchia G, Martino B, Scalzulli PR, Latagliata R, Palmieri F, Usala E, Valente D, Valvano MR, Cedrone M, Comitini G, Martinelli V, Cascavilla N, Gugliotta L. Melillo L, et al. Among authors: scalzulli pr. Am J Hematol. 2009 Oct;84(10):636-40. doi: 10.1002/ajh.21504. Am J Hematol. 2009. PMID: 19705431 Free article.

2

Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia.

Musto P, Bodenizza C, Falcone A, D'Arena G, Scalzulli P, Perla G, Modoni S, Parlatore L, Valvano MR, Carotenuto M. Musto P, et al. Br J Haematol. 1995 May;90(1):125-30. doi: 10.1111/j.1365-2141.1995.tb03390.x. Br J Haematol. 1995. PMID: 7786774

3

Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.

Sajeva MR, Greco MM, Cascavilla N, D'Arena G, Scalzulli P, Melillo L, Minervini MM, Bonini A, Di Mauro L, Carotenuto M, Musto P. Sajeva MR, et al. Bone Marrow Transplant. 1996 Jul;18(1):225-7. Bone Marrow Transplant. 1996. PMID: 8832022

4

Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies.

D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR, Matera R, Carotenuto M. D'Arena G, et al. Among authors: scalzulli pr. Am J Hematol. 1998 Aug;58(4):255-62. doi: 10.1002/(sici)1096-8652(199808)58:4<255::aid-ajh1>3.0.co;2-p. Am J Hematol. 1998. PMID: 9692386 Free article.

5

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Cascavilla N, Melillo L, Scalzulli PR, Dell'Olio M, La Sala A, Mantuano S, Nobile M, Carella AM. Musto P, et al. Among authors: scalzulli pr. Leuk Lymphoma. 2003 Sep;44(9):1545-8. doi: 10.3109/10428190309178778. Leuk Lymphoma. 2003. PMID: 14565658 Clinical Trial.

6

Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM, Cascavilla N, Dell'Olio M, La Sala A, Mantuano S, Melillo L, Nobile M, Scalzulli PR, Bisceglia M, Carella AM. Musto P, et al. Among authors: scalzulli pr. Leuk Lymphoma. 2004 Jun;45(6):1219-22. doi: 10.1080/10428190310001641143. Leuk Lymphoma. 2004. PMID: 15360005

7

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.

Musto P, Lanza F, Balleari E, Grossi A, Falcone A, Sanpaolo G, Bodenizza C, Scalzulli PR, La Sala A, Campioni D, Ghio R, Cascavilla N, Carella AM. Musto P, et al. Among authors: scalzulli pr. Br J Haematol. 2005 Jan;128(2):204-9. doi: 10.1111/j.1365-2141.2004.05288.x. Br J Haematol. 2005. PMID: 15638854 Free article.

8

Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide.

Musto P, Falcone A, Sanpaolo G, Guglielmelli T, Zambello R, Balleari E, Catalano L, Spriano M, Cavallo F, La Sala A, Mantuano S, Nobile M, Melillo L, Scalzulli PR, Dell'Olio M, Bodenizza C, Greco MM, Carella AM Jr, Merla E, Carella AM, Boccadoro M, Cascavilla N, Palumbo A. Musto P, et al. Among authors: scalzulli pr. Leuk Res. 2006 Mar;30(3):283-5. doi: 10.1016/j.leukres.2005.06.027. Epub 2005 Aug 18. Leuk Res. 2006. PMID: 16111749 Free article. Clinical Trial.

9

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature.

Musto P, Scalzulli PR, Terruzzi E, Rossini F, Iacopino P, Messina G, Guariglia R, Pietrantuono G, Villani O, D'Auria F, Falcone A, Sanpaolo G, Valvano MR, Pogliani EM, Morabito F. Musto P, et al. Among authors: scalzulli pr. Leuk Res. 2007 Nov;31(11):1487-93. doi: 10.1016/j.leukres.2007.01.008. Epub 2007 Feb 23. Leuk Res. 2007. PMID: 17320951

10

Attenuated doses of rituximab for the treatment of adults with autoimmune cytopenias.

D'arena G, Scalzulli PR, Nobile M, Dell'olio M, Rossi G, Cascavilla N. D'arena G, et al. Among authors: scalzulli pr. Am J Hematol. 2008 Aug;83(8):686-7. doi: 10.1002/ajh.21203. Am J Hematol. 2008. PMID: 18508322 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page